6 Health Issues Eye Doctors Can Spot At Your Appointment
Unfortunately, many diseases aren’t always straightforward and simple like we want them to be. For starters, certain health…
Mitrix moves mitochondria into the clinic
Early human safety data and new US clinics signal a shift from theory to real-world testing for mitochondrial…
Eli Lilly Just Launched Its $149 Obesity Pill – Eli Lilly (NYSE:LLY)
Eli Lilly and Co. (NYSE:LLY) on Wednesday announced that Foundayo (orforglipron) is now available to adults with obesity…
Private firms providing services to NHS made £1.6bn profit in two years, research finds | NHS
Private firms providing services to the NHS including healthcare and consultancy have made £1.6bn in profits over the…
Doctor sounds warning – The Fiji Times
Fiji’s health system is expected to face increasing pressure as HIV and tuberculosis (TB) cases continue to rise,…
Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial
Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer…
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide
Just days before Christmas 2025, leaders of nine pharmaceutical companies clustered in the Roosevelt Room of the White…
Waxers, doctors, and nurses share their unfiltered inner thoughts about your ‘privates.’
Most of us have a self-improvement checklist. Exercise more. Stress less. Sleep better. Be more present. It’s a…
Is This Biotech Stock the Best Chance to Make a Fortune in Healthcare?
Investing in smaller biotechs can yield outstanding returns over the long run if they make sufficient regulatory and…
8 Healthcare Stocks Insiders Are Buying
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were…
CDC Caught Burying Report on Real Effects of COVID Vaccine
Sign up to see the future, today Can’t-miss innovations from the bleeding edge of science and tech The…
Johnson & Johnson Vs. Pfizer
As large tech companies struggled this year, investors have had a chance to reevaluate their portfolios and identify…